Wrong time to get bullish: Top investor warns deflating tech ‘bubble’ far from over

Wrong time to get bullish: Top investor warns deflating tech ‘bubble’ far from over


The recent tech rally may be doomed.

Money manager Dan Suzuki of Richard Bernstein Advisors warns the market is far from bottoming — and it’s a concept investors fail to grasp, particularly when it comes to growth, technology and innovation names.

“The two certainties in this world of uncertainty today is that profits growth is going to continue to slow and liquidity is going to continue to tighten,” the firm’s deputy chief investment officer told CNBC’s “Fast Money” on Tuesday. “That’s not a good environment to be jumping into these speculative bubble stocks.”

Fresh off the holiday weekend, the tech-heavy Nasdaq bounced back from a 216-point deficit to close almost 2% higher. The S&P 500 also mustered a turnaround, erasing a 2% loss earlier in the day. The Dow closed 129 points lower after being off 700 points in the session’s early hours.

Suzuki suggests investors are playing with fire.

It’s kind of a do not touch story,” he said. “The time to be bullish on these stocks as a whole is if we are going to see signs of a bottoming in profits or you’re seeing signs that liquidity is going to get pumped back into the system.”

However, the Federal Reserve has been taking back the punch bowl. And it has serious implications for almost all U.S. stocks, according to Suzuki.

“Whatever company you want to pick, whether it’s the cheapest companies, the companies that are putting up the best cash flows or the highest quality companies, the thing that they all have in common is that they benefit tremendously from the past five years of record liquidity,” he said. “It basically created a bubble.”

Suzuki and his firm’s bubble call stems back to June 2021. Last May, Suzuki told “Fast Money” a bubble was hitting 50% of the market. He’s still telling investors to play defense and target contrarian plays.

“Look for things that are bucking the trend, things that have a lot of positive, absolute upside from here,” said Suzuki, who’s also a former Bank of America-Merrill Lynch market strategist.

But the best option may be going halfway around the world. He only sees China as attractive, and investors will need a 12 to 18 month time horizon.

China: ‘Precipice’ of bull market?

“China’s market [is] much, much cheaper on a valuation basis. From a liquidity perspective, they’re like the only major economy out there that’s trying to pump liquidity into its economy,” noted Suzuki. “That’s the opposite of what you’re seeing outside of China and the rest of the world.”

He believes it could be on the “precipice” of a bull market as long as profits growth carries into the broader economy.

Even if he’s right, Suzuki urges investors to be prudent.

“If we’re in a global slowdown that may ultimately turn into a global recession, this is not the time to be pedal to the medal in risk anywhere in the portfolio,” Suzuki said.

Disclaimer



Source

We spoke to over 30 CEOs and business leaders. Here’s what worries them most
World

We spoke to over 30 CEOs and business leaders. Here’s what worries them most

Business leaders are confronting a new operating reality: one where war, inflation, AI and supply chain shocks are no longer exceptional events, but part of the baseline. CNBC spoke to more than 30 CEOs, business executives and industry leaders at the annual Converge Live event in Singapore last week. Across sectors — banking, energy, shipping, […]

Read More
U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets
World

U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets

A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 16, 2026. Jeenah Moon | Reuters Global markets are entering the week balancing resilient risk appetite against renewed geopolitical strain as prospects of U.S.-Iran negotiations took a hit over the weekend. U.S. President Donald Trump scrapped […]

Read More
Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in .75 billion deal
World

Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

SHANGHAI, CHINA – NOVEMBER 05: People visit the booth of Organon during the 7th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November 5, 2024 in Shanghai, China. The 7th China International Import Expo (CIIE) kicked off in Shanghai on November 5. (Photo by Tang Yanjun/China News Service/VCG via […]

Read More